Global HIV/AIDS Drugs Market (2022 to 2027) - Featuring AbbVie, Cipla, Gilead Sciences and GSK Among Others - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--Sep 14, 2022--

The "Global HIV/AIDS Drugs Market (2022-2027) by Medication Class, Distribution Channel, Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis" report has been added to ResearchAndMarkets.com's offering.

The Global HIV/AIDS Drugs Market is estimated to be USD 30.12 Bn in 2022 and is expected to reach USD 39.93 Bn by 2027, growing at a CAGR of 5.8%.

Market dynamics are forces that impact the prices and behaviors of the Global HIV/AIDS Drugs Market stakeholders. These forces create pricing signals which result from the changes in the supply and demand curves for a given product or service. Forces of Market Dynamics may be related to macro-economic and micro-economic factors.

There are dynamic market forces other than price, demand, and supply. Human emotions can also drive decisions, influence the market, and create price signals. As the market dynamics impact the supply and demand curves, decision-makers aim to determine the best way to use various financial tools to stem various strategies for speeding the growth and reducing the risks.

Competitive Quadrant

The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Ansoff Analysis

The report presents a detailed Ansoff matrix analysis for the Global HIV/AIDS Drugs Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach. The analyst analyses the Global HIV/AIDS Drugs Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position. Based on the SWOT analysis conducted on the industry and industry players, the analyst has devised suitable strategies for market growth.

Why buy this report?

• The report offers a comprehensive evaluation of the Global HIV/AIDS Drugs Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
• The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
• The report includes an in-depth market analysis using Porter's 5 forces model and the Ansoff Matrix. In addition, the impact of Covid-19 on the market is also featured in the report.
• The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
• The report also contains the competitive analysis using Positioning Quadrants, the analyst's Proprietary competitive positioning tool.

Market Dynamics

Drivers

• Increase In Number of HIV Infected Patients Worldwide
• Initiatives and Awareness Drives by Governments

Restraints

• Stringent Regulatory Requirements for the Drugs Approval

Opportunities

• Increase R&D Initiatives for the Development of the Long-Acting Suppression Antiretroviral Therapy

Challenges

• Commercialization of HIV Drugs

Market Segmentation

The Global HIV/AIDS Drugs Market is segmented based on Medication Class, Distribution Channel, and Geography.

• By Medication Class, the market is classified into Multi-class Combination Drugs, Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs), Protease Inhibitors (PIs), Entry Inhibitors, and HIV Integrase Strand Transfer Inhibitors.
• By Distribution Channel, the market is classified into Hospitals, Retail, Online, and Others.
• By Geography, the market is classified into Americas, Europe, Middle-East & Africa and Asia-Pacific.

Companies Mentioned

• AbbVie Inc.
• Bristol-Myers Squibb Company
• C.H. Boehringer Sohn AG & Ko. KG
• Cipla Ltd.
• F. Hoffmann-La Roche AG
• Gilead Sciences, Inc.
• GSK plc
• Johnson & Johnson Pvt. Ltd.
• Merck & Co. Inc.
• Mylan N.V.
• Pfizer Inc.
• Teva Pharmaceutical Industries Ltd.
• ViiV Healthcare

For more information about this report visit https://www.researchandmarkets.com/r/czs43h

View source version on businesswire.com:https://www.businesswire.com/news/home/20220914005814/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.comFor E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: AIDS PHARMACEUTICAL HEALTH

SOURCE: Research and Markets

Copyright Business Wire 2022.